Literature DB >> 10759658

Transurethral implantation of silicone polymer for stress incontinence: evaluation of a porcine model and mechanism of action in vivo.

S C Radley1, C R Chapple, J A Lee.   

Abstract

OBJECTIVE: To evaluate the anatomical location, histological appearances and mechanism of action of sili-cone polymer (Macroplastique(R)) after transurethral implantation.
MATERIALS AND METHODS: An in vivo pig model was developed to investigate the organization of Macroplastique 6 weeks after injection. The results were compared with the immediate appearance of injected Macroplastique in a surgical training device (using isolated pig urethrae) and with the histological appearances of Macroplastique in an explanted human specimen.
RESULTS: Macroplastique was subserosal in all specimens; it provoked a marked foreign-body inflammatory reaction, producing firm nodules 6 weeks after implantation. The histological appearances in the in vivo pig model and the human specimen were indistinguishable.
CONCLUSIONS: These findings indicate that the mechanism of action of Macroplastique is to augment pressure transmission to the proximal urethra by producing focal but firm expansion of periurethral tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759658     DOI: 10.1046/j.1464-410x.2000.00515.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

Review 1.  Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency.

Authors:  Christopher James Hillary; Nadir Osman; Christopher Chapple
Journal:  World J Urol       Date:  2015-06-10       Impact factor: 4.226

Review 2.  Treatment options for intrinsic sphincter deficiency.

Authors:  Sovrin M Shah; Geoffrey S Gaunay
Journal:  Nat Rev Urol       Date:  2012-10-02       Impact factor: 14.432

3.  The female continence mechanism measured by high resolution manometry: Urethral bulking versus midurethral sling.

Authors:  Erika J Wasenda; Anna C Kirby; Emily S Lukacz; Charles W Nager
Journal:  Neurourol Urodyn       Date:  2018-02-21       Impact factor: 2.696

4.  Effect of the Macroplastique Implantation System for stress urinary incontinence in women with or without a history of an anti-incontinence operation.

Authors:  Ilknur Inegol Gumus; Ikbal Kaygusuz; Aysel Derbent; Serap Simavli; Hasan Kafali
Journal:  Int Urogynecol J       Date:  2011-04-02       Impact factor: 2.894

Review 5.  Treatment of stress urinary incontinence: recent developments in the role of urethral injection.

Authors:  Philip van Kerrebroeck; Flip ter Meulen; Elisabeth Farrelly; Gregor Larsson; Lena Edwall; Aino Fianu-Jonasson
Journal:  Urol Res       Date:  2003-01-30

6.  Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women.

Authors:  Ph H ter Meulen; L C M Berghmans; F H M Nieman; Ph E V A van Kerrebroeck
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-10-21

7.  Local giant cell foreign body reaction after silicone injection for fecal incontinence in humans: two case reports.

Authors:  B van Wunnik; A Driessen; C Baeten
Journal:  Tech Coloproctol       Date:  2011-06-22       Impact factor: 3.781

Review 8.  Emerging periurethral bulking agents for female stress urinary incontinence: is new necessarily better?

Authors:  Jonathan S Starkman; Harriette Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

9.  Urolastic-a new bulking agent for the treatment of women with stress urinary incontinence: outcome of 12 months follow up.

Authors:  Janusz Zajda; Fawzy Farag
Journal:  Adv Urol       Date:  2013-12-22

10.  Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up.

Authors:  Janusz Zajda; Fawzy Farag
Journal:  Cent European J Urol       Date:  2015-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.